Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2006 Feb 1;44(3):157-60.

[Simultaneous liver-pancreas-duodenum transplantation: one case report and review of the literature]

[Article in Chinese]
Jian Xu  1 , Li-xin Yu, Wen-feng Deng, Shao-jie Fu, Chuan-fu Du, Yi-bin Wang, Xiao-you Liu, Yun Miao, Chuan-jiang Li, Jun-sheng Ye
Affiliations
  • PMID: 16635342
Case Reports

[Simultaneous liver-pancreas-duodenum transplantation: one case report and review of the literature]

[Article in Chinese]
Jian Xu et al. Zhonghua Wai Ke Za Zhi. .

Abstract

Objective: To investigate the effect of treatment on end-stage liver disease and type-I diabetes mellitus with simultaneous liver-pancreas-duodenum transplantation.

Method: In September 2003, one patient with chronic hepatitis B, liver cirrhosis, hepatic cellular cancer, and insulin-dependent diabetes received simultaneous orthotopic liver and heterotopic pancreas-duodenum transplantation. Liver and pancreas graft function was monitored after transplantation.

Results: The function of pancreas allograft was recovered immediately and the patient became insulin-independence postoperatively. The liver allograft was experienced an acute rejection episode and reversed by intravenous bolus methylprednisolone. The recipient was currently liver disease-free and insulin-free more than 21 months.

Conclusions: The simultaneous liver-pancreas-duodenum transplantation is an effective method in the treatment of end-stage liver disease and type-I diabetes mellitus.

PubMed Disclaimer

Substances